EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Jun 30, 2026
What This Signal Is
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
Market Context
Market conditions on June 30, 2026 present a broadly constructive backdrop for trend-following signals. All three major indices closed higher, with the Nasdaq leading at +1.48%, suggesting that growth and momentum-oriented assets are attracting the most buying interest. This kind of broad-based advance, anchored by tech sector strength, tends to validate EMA crossover strategies by producing cleaner, more sustained directional moves rather than choppy, range-bound price action.
Volatility is notably subdued, with the VIX dropping nearly 7% to sit at 16.46 — a level that reflects measured risk appetite rather than complacency or fear. For EMA-based signals, lower volatility generally reduces the frequency of false crossovers and whipsaws, improving signal quality. Intraday price swings are likely to remain contained, which can help short-to-medium-term trend signals play out more reliably without being disrupted by erratic price spikes.
The Technology sector leading signal generation aligns well with the Nasdaq's outperformance and points to active sector rotation favoring growth over defensives. With 53 signals firing under the ema10/ema30 framework, the market appears to be in a phase where momentum is building across multiple names within that space. Traders should remain attentive to whether this rotation broadens out or remains concentrated, as a narrowing leadership base can sometimes precede short-term consolidation even within an otherwise healthy trend environment.
🟢 Buy Signals (15 of 31 total)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ALKT | Alkami Technology, Inc. | Technology | $18.12 | — | $1.9B |
| 2 | AUR | Aurora Innovation, Inc. | Technology | $6.82 | +$498,300 | $13.4B |
| 3 | AWI | Armstrong World Indust... | Industrials | $160.42 | — | $6.8B |
| 4 | CCC | CCC Intelligent Soluti... | $5.16 | — | $3.0B | |
| 5 | CRNX | Crinetics Pharmaceutic... | Healthcare | $37.42 | -$22,022 | $3.9B |
| 6 | DBX | Dropbox, Inc. | Technology | $27.47 | — | $7.0B |
| 7 | EEFT | Euronet Worldwide, Inc. | Technology | $73.19 | — | $2.8B |
| 8 | FLO | Flowers Foods, Inc. | Consumer Defensive | $7.91 | — | $1.7B |
| 9 | GMAB | Genmab A/S | Healthcare | $27.47 | — | $16.9B |
| 10 | GPN | Global Payments Inc. | Industrials | $72.56 | — | $17.2B |
| 11 | GRAB | Grab Holdings Limited | Technology | $3.77 | -$2,183,316 | $14.9B |
| 12 | IBP | Installed Building Pro... | Consumer Cyclical | $229.84 | +$32,045 | $6.2B |
| 13 | IDCC | InterDigital, Inc. | Technology | $283.13 | -$596,374 | $7.3B |
| 14 | ITRI | Itron, Inc. | Technology | $86.53 | — | $3.8B |
| 15 | LPTH | LightPath Technologies... | Technology | $16.35 | — | $783M |
🔴 Sell Signals (5 of 22 total)
Ranked by RSI (higher RSI for sell signals = more overbought)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ADI | Analog Devices, Inc. | Technology | $397.17 | — | $193.5B |
| 2 | ALSN | Allison Transmission H... | Consumer Cyclical | $112.74 | — | $9.4B |
| 3 | ATKR | Atkore Inc. | Industrials | $76.04 | — | $2.6B |
| 4 | BEP | Brookfield Renewable P... | Utilities | $34.73 | — | $10.5B |
| 5 | COLM | Columbia Sportswear Co... | Consumer Cyclical | $61.82 | — | $3.2B |
Field Notes
Sector concentration: Technology (13), Industrials (8), Healthcare (8)
Insider selling: GRAB (Grab Holdings Limited, -$2,183,316), IDCC (InterDigital, Inc., -$596,374), CRNX (Crinetics Pharmaceuticals, Inc., -$22,022)
Insider buying: IBP (Installed Building Products, Inc., +$32,045), AUR (Aurora Innovation, Inc., +$498,300)
Data coverage: 20.8% insider, 3.8% congressional, 0.0% earnings, 11.3% news
Peer Analysis
AUR (Aurora Innovation, Inc.): Leads 5 peers: APLD ($37.30), EPAM ($79.35), JKHY ($137.74), TTAN ($70.71), OTEX ($22.15)
GPN (Global Payments Inc.): Leads 5 peers: RBA ($116.45), ULS ($101.86), SNA ($402.40), LII ($572.95), CHRW ($188.34)
Congressional Activity
ADI (Analog Devices, Inc.) 🟢 Bullish
- 1 purchase by 1 member
IBP (Installed Building Products, Inc.) 🟢 Bullish
- 1 purchase by 1 member
Recent Headlines
ALKT (Alkami Technology, Inc.)
- MANTL Surpasses $40 Billion in Deposits Raised on the Platform and Saves Financial Institutions More Than 1 Million Hours on Account Opening
ALSN (Allison Transmission Holdings, Inc.)
- Allison Transmission Holdings Set to Join S&P MidCap 400 and Goodyear Tire & Rubber to Join S&P SmallCap 600
- Allison Transmission: Attractive Valuation Despite Near-Term Headwinds
Vlad's Take
Today's signals: Strong sector concentration in Technology (13 signals) suggests sector-specific rotation. 2 signals with insider buying adds conviction. 9 signals showing insider selling warrant caution. 2 signals with congressional buying shows lawmaker confidence.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.